Controlled induction and targeted elimination of p16(INK4a)-expressing chondrocytes in cartilage explant culture

Article

关键词: SENESCENT CELLS;    IN-VIVO;    CELLULAR SENESCENCE;    OSTEOARTHRITIS;    P16(INK4A);    EXPRESSION;    CLEARANCE;    BIOMARKER;    DISEASE;    MICE;   

DOI  :  10.1096/fj.201900815RR

来源: SCIE

【 摘 要 】

Cellular senescence is a phenotypic state that contributes to age-related diseases through the secretion of matrix-degrading and inflammatory molecules. An emerging therapeutic strategy for osteoarthritis (OA) is to selectively eliminate senescent cells by initiating apoptosis. This study establishes a cartilage explant model of senescence induction and senolytic clearance using p16(Ink4a) expression as a biomarker of senescence. Growth-factor stimulation of explants increased the expression of p16(Ink4a) at both the mRNA and protein levels. Applying this culture system to cartilage from p16tdTom reporter mice (a knockin allele with tdTomato fluorescent protein regulated by the endogenous p16Ink4a promoter) demonstrated the emergence of a p16-high population that was quantified using flow cytometry for tdTomato. Cell sorting was used to separate chondrocytes based on tdTomato fluorescence and p16-high cells showed higher senescence-associated beta-galactosidase activity and increased gene expression of the senescence-associated secretory phenotype as compared with p16-low cells. The potential for effective senolysis within the cartilage extracellular matrix was assessed using navitoclax (ABT-263). Navitoclax treatment reduced the percentage of p16-high cells from 17.9 to 6.1% (mean of 13 matched pairs; P < 0.001) and increased cleaved caspase-3 confirmed apoptotic activity. Together, these findings establish a physiologically relevant cartilage explant model for testing the induction and elimination of senescent chondrocytes, which will support investigations of senolytic therapy for OA.

【 授权许可】

Free